Undervalued Large-Cap Healthcare Stocks on NYS October 2024

October 18, 2024

Healthcare Sector

The healthcare sector includes companies in biotechnology, pharmaceuticals, hospitals, home and long-term care. It also includes related medical equipment manufacturers and suppliers.

New York Stock Exchange

The New York Stock Exchange, located in New York City, is the largest securities exchange in the world by market capitalization of its listed companies.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued Healthcare stocks

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
PRGO Perrigo 25.30 50.15 98.21 1467820 3469 4.41 0.0
ELAN Elanco Animal Health 13.26 26.07 96.60 5176427 6553 0.00 0.0
NVST Envista Holdings 18.18 33.96 86.83 1875656 3129 0.00 0.0
CRL Charles River 195.11 350.57 79.68 659308 10116 0.00 23.7
FMS Fresenius Medical Care 20.03 34.98 74.62 221601 11754 3.21 20.3
OSCR Oscar Health 17.80 30.16 69.45 2876036 5411 0.00 0.0
CTLT Catalent 60.28 71.40 18.44 1627628 10911 0.00 0.0
ZBH Zimmer Biomet Holdings 104.95 119.62 13.98 1464614 21662 0.91 21.9
GSK GSK 39.21 44.66 13.91 5234185 80812 3.93 13.2
AVTR Avantor 24.79 28.12 13.42 5090648 16922 0.00 47.6
All data provided as at market close October 16, 2024.

Company Details

Perrigo

PRGO:NYS

Close Price

25.30

Our Valuation

50.15

% Difference

98.21

Market Cap ($M)

3469

P/E Ratio

0.0

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS.

Access the stockcalc valuation


Elanco Animal Health

ELAN:NYS

Close Price

13.26

Our Valuation

26.07

% Difference

96.60

Market Cap ($M)

6553

P/E Ratio

0.0

Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries.

Access the stockcalc valuation


Envista Holdings

NVST:NYS

Close Price

18.18

Our Valuation

33.96

% Difference

86.83

Market Cap ($M)

3129

P/E Ratio

0.0

Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables.

Access the stockcalc valuation


Charles River

CRL:NYS

Close Price

195.11

Our Valuation

350.57

% Difference

79.68

Market Cap ($M)

10116

P/E Ratio

23.7

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Fresenius Medical Care

FMS:NYS

Close Price

20.03

Our Valuation

34.98

% Difference

74.62

Market Cap ($M)

11754

P/E Ratio

20.3

Fresenius Medical Care is the largest dialysis company in the world, treating over 300,000 patients from roughly 3,750 clinics across the globe as of mid-2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business.

Access the stockcalc valuation


Oscar Health

OSCR:NYS

Close Price

17.80

Our Valuation

30.16

% Difference

69.45

Market Cap ($M)

5411

P/E Ratio

0.0

Oscar Health Inc is a health insurance company. The company provides various insurance plans for individuals, families, and employees. Also, the company provides virtual care, doctor support, scheduling appointments, and other related services. The company provides plans in the Medicare Advantage program to adults who are age 65 and older and eligible for traditional Medicare but who instead select coverage through a private market plan.

Access the stockcalc valuation


Catalent

CTLT:NYS

Close Price

60.28

Our Valuation

71.40

% Difference

18.44

Market Cap ($M)

10911

P/E Ratio

0.0

Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers.

Access the stockcalc valuation


Zimmer Biomet Holdings

ZBH:NYS

Close Price

104.95

Our Valuation

119.62

% Difference

13.98

Market Cap ($M)

21662

P/E Ratio

21.9

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products.

Access the stockcalc valuation


GSK

GSK:NYS

Close Price

39.21

Our Valuation

44.66

% Difference

13.91

Market Cap ($M)

80812

P/E Ratio

13.2

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Access the stockcalc valuation


Avantor

AVTR:NYS

Close Price

24.79

Our Valuation

28.12

% Difference

13.42

Market Cap ($M)

16922

P/E Ratio

47.6

Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Perrigo and Elanco Animal Health are the most undervalued Large-Cap Healthcare stocks on the NYS. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-large-cap-healthcare-stocks-nys-october-2024
Perrigo $PRGO and Elanco Animal Health $ELAN are the most undervalued Healthcare stocks on the #NYS. See the full list: https://www.stockcalc.com/Blog/undervalued-large-cap-healthcare-stocks-nys-october-2024
Perrigo and Elanco Animal Health are the most undervalued Large-Cap Healthcare stocks on the NYS. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-large-cap-healthcare-stocks-nys-october-2024

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.